Milatuzumab (Anti-CD74)

Milatuzumab (Anti-CD74) is a humanized monoclonal antibody targeting CD74, a integral membrane protein. Milatuzumab causes free radical oxygen generation, and loss of mitochondrial membrane potential. Milatuzumaba also decreases CD20/CD74 aggregates and cell adhesion, to lead to cell death. MW:145.5 KD.
Supplier Selleck Chemicals
Product # A2551
Sku # A2551-1mg*5
Pricing 1mg*5, $970.00
Feedback